30: Off Label Drugs In Cancer

Off-label medications are a hot topic in the cancer world right now.

You’re hearing names like GLP-1s, ivermectin, and fenbendazole tossed around in comments, DMs, and late-night Google searches… but when you go looking for clear, trustworthy information?

There’s not much.

So I brought in the best person I know for this conversation: Dr Paul Anderson. Dr. Anderson has spent decades working at the intersection of integrative medicine, complex chronic illness, and cancer.

 

One of the most important takeaways: the world of repurposed medications is much bigger than what’s trending on social media. There are many categories that researchers and clinicians explore in oncology, including:

• diabetes medications
• statins (cholesterol medications)
• antibiotics
• antifungal medications
• antiviral medications, and more

In this conversation, we focus on the ones people are asking about the most right now — GLP-1s and popular antiparasitics like ivermectin and fenbendazole — and we talk through what they do, why they’re being discussed, and what to watch for.

 

🔗 Episode Relevant Resources:

• I highly recommend checking out Dr Anderson's books at https://dranow.com/
• You can find Dr Anderson on Youtube: www.youtube.com/@DrA-Online
• E22 How To Block Cancer Recurrence by Changing The Tumor Neighbourhood: https://youtu.be/x9nQeqEPYzw
• E25 Does Sugar Really Feed Cancer?: https://youtu.be/XiWJ1betH5w
• E11 STOP Killing Cancer Cells - You’re Wasting Your Time. Do This Instead: https://youtu.be/3TP3jZ7T4fk

⚠️ This is a must-listen if:

• You keep hearing about off-label meds and feel unsure what’s real vs hype
• You want to reduce recurrence risk without taking a “throw everything at it” approach
• You’re curious about GLP-1s, ivermectin, or fenbendazole — but want context and safety
• You want to understand how these tools relate to the tumor microenvironment
• You want guidance that supports both your long-term health and your nervous system

💊 In this episode, you’ll learn:

• Why off-label medications are being explored in cancer care — and why this category is broader than most people realize
• What GLP-1s may suggest about cancer risk and longevity, and what we still don’t know yet
• Why antiparasitics like ivermectin and benzimidazoles (including fenbendazole) show up in oncology conversations
• How these drugs may influence the tumor microenvironment — and why that matters in recurrence prevention
• The key risks, limitations, and monitoring considerations that often get skipped online

💡 You’ll leave this episode with:

• A clearer way to think about off-label meds without fear-based urgency
• Better questions to ask before adding any medication to your plan
• A stronger understanding of why foundations (food, movement, metabolic health, muscle mass) still matter most
• More confidence in what’s worth exploring — and what’s probably not

I’m Dr Megan, a licensed naturopathic doctor. My team and I support women after cancer with research-backed nutrition, lifestyle, and personalized strategies to reduce recurrence risk — so they can feel strong, clear, and supported in their next chapter.

 

✨ Let’s Connect

Book a free Roadmap Call:

👉 https://www.flourishaftercancer.com/nextsteps

 

Follow along:

Instagram: @MeganBernardND

Facebook: @MeganBernardND

Website: https://www.flourishaftercancer.com

 

Medical Disclaimer:

The information shared in this podcast is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before making changes to medications, supplements, or lifestyle. This content is not a substitute for individualized medical advice or care.